| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436344 Method of inactivating pathogens |
| 08/20/2002 | CA2225530C A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 08/20/2002 | CA2164321C Plasma-like solution |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2068700C Active oxygen scavenger |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/16/2002 | CA2361108A1 Composition and method for growing hair |
| 08/15/2002 | WO2002062971A1 Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells or the preconditioned cells |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062969A2 Cellular reprogramming in peptide hydrogel and uses thereof |
| 08/15/2002 | WO2002062968A2 Micro-tubular materials and cell constructs |
| 08/15/2002 | WO2002062967A2 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | WO2002062961A2 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062395A2 A method and system for introducing a gene into a human stem cell |
| 08/15/2002 | WO2002062392A2 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002062366A1 Herbal composition for_the prevention and treatment of dementia |
| 08/15/2002 | WO2002062363A1 Herbal extract and preparation thereof |
| 08/15/2002 | WO2002062362A2 Antiviral and antibacterial composition |
| 08/15/2002 | WO2002062361A1 Antiviral composition containing propolis and essential oils |
| 08/15/2002 | WO2002062360A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 08/15/2002 | WO2002062359A1 Preparation of cartilage extracts using organic solvents |
| 08/15/2002 | WO2002062358A1 Cell suspension preparation technique and device |
| 08/15/2002 | WO2002062357A1 Methods and devices for tissue repair |
| 08/15/2002 | WO2002062351A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002039948A3 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002026939A3 Microfabrication of membranes for the growth of cells |
| 08/15/2002 | WO2002024932A3 Expression vectors containing hybrid ubiquitin promoters |
| 08/15/2002 | WO2002024609A3 Method for producing a radioprotector |
| 08/15/2002 | WO2002019966A3 Cardiac arrhythmia treatment methods |
| 08/15/2002 | WO2002017980B1 Methods and compositions for tissue regeneration |
| 08/15/2002 | WO2002010345A3 Autologous bio-matrix from mammalian liver |
| 08/15/2002 | WO2002008751A3 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 08/15/2002 | WO2001098516A3 Siderophores-producing bifidobacteria thereby and uses thereof |
| 08/15/2002 | WO2001091763A3 Extracts from spermatophyte plants with antitumor activity |
| 08/15/2002 | WO2001090319A3 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
| 08/15/2002 | WO2001085183A3 Preparation for the prevention and treatment of ocular disorders |
| 08/15/2002 | WO2001081551A9 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | US20020112254 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 08/15/2002 | US20020111695 Reconstituted mineralized cartilage tissue |
| 08/15/2002 | US20020111676 Cardiovascular components for transplantation and methods of making thereof |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020110914 Platelet suspensions and methods for resuspending platelets |
| 08/15/2002 | US20020110898 Attenuating endogenous genes in cell; obtain cell, transform with vectors conding restriction enzymes, recover and propagate transformed cells |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110544 Osteoarthritis cartilage regeneration |
| 08/15/2002 | US20020110543 Viral delivery system for infectious transfer of large genomic DNA inserts |
| 08/15/2002 | US20020110541 Can be mixed into a paste and then loaded into a syringe and ejected for an extended period of time (e.g., more than ten minutes); can be mixed into a putty and then handled and formed into desired shapes for an extended period of time |
| 08/15/2002 | US20020110540 Disease prevention by reactivation of the thymus |
| 08/15/2002 | CA2437648A1 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | CA2437212A1 Methods and devices for tissue repair |
| 08/15/2002 | CA2436374A1 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | CA2436264A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 08/15/2002 | CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | CA2435586A1 Preparation of cartilage extracts using organic solvents |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231263A1 Multipotent O-2A progenitors from the neurohypophysis |
| 08/14/2002 | EP1231262A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 08/14/2002 | EP1230920A1 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 08/14/2002 | EP1230911A1 cosmetic or pharmaceutical preparation |
| 08/14/2002 | EP1230394A1 Lentiviral vector transduction of hematopoietic stem cells |
| 08/14/2002 | EP1230378A2 An oncolytic adenovirus |
| 08/14/2002 | EP1230375A1 Inhibiting gene expression with dsrna |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230346A2 Method for enhancing t cell reactivity toward tumour antigens |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1229941A2 Nucleic acid-containing complex |
| 08/14/2002 | EP1229930A1 Compositions and methods for treatment of allergic disorders |
| 08/14/2002 | EP1229923A1 Inhibition of pathogens by bacillus coagulans strains |
| 08/14/2002 | EP1229922A2 Aplidine treatment of cancers |
| 08/14/2002 | EP1229895A1 Slimming composition containing a substance inducing il-6 production |
| 08/14/2002 | EP1229795A2 Human chemokine beta-13 |
| 08/14/2002 | EP1229790A1 MODULATION OF $g(g)$g(d) T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 08/14/2002 | EP0800399B1 Combined therapeutical treatment of hyperproliferative diseases |
| 08/14/2002 | EP0697876B1 Xenograft thymus |
| 08/14/2002 | DE10158523A1 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue |
| 08/14/2002 | DE10105420A1 In vitro Zellinteraktionskultursystem für Medikamententestung und -entwicklung In vitro cell culture system for drug interaction testing and development |
| 08/14/2002 | CN1364076A Oral form of administration containing probiotic micro-organisms |